Gil Rosen

COO at CuResponse

Mr. Rosen brings over 20 years of experience in developing and introducing oncology-related technologies to international markets. He previously served as CEO of BioProtect, and prior to that served as CCO of Dune Medical.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


CuResponse

Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.


Employees

11-50

Links